MEDIOCON INC offers Bacillus licheniformis SL307, a specific strain of Bacillus licheniformis used as a spore-forming probiotic and functional microbial ingredient. The SL307 strain is listed in scientific literature among commercially used Bacillus probiotic strains.
Bacillus licheniformis SL307 is characterized as a spore-forming bacterial strain and is used in spore-based probiotic formulations. Its spore-forming nature supports stability during processing and storage compared with many non-spore-forming probiotic microorganisms.
In India, Bacillus licheniformis SL307 is listed by the Food Safety and Standards Authority of India (FSSAI) under application reference 66/Std/PA/FSSAI/2020, dated 09.07.2021, with Food Category 99.6. The FSSAI record identifies M/s Synergia Life Sciences Pvt. Ltd., Mumbai as the applicant.
MEDIOCON INC supplies Bacillus licheniformis SL307 for applicable food, nutraceutical and functional-ingredient applications according to the required product specification and quality documentation
| Parameter | Specification |
|---|---|
| Appearance | As per current product specification |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Bacillus licheniformis SL307 Manufacturer & Supplier in India | MEDIOCON INC and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Bacillus licheniformis SL307 Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance